ALTANA Pharma

Cities in Iowa, Iowa

0 studies enrolling now · 3 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease

Studies at this site

• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111) — Completed
• Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) — Completed
• Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012) — Completed